Printer Friendly

BIOWHITTAKER SATISFIES CASH OBLIGATION TO 3M DIAGNOSTIC SYSTEMS

 WALKERSVILLE, Md., Feb. 5 /PRNewswire/ -- BioWhittaker, Inc. (NYSE: BWI) announced that is has satisfied in cash its obligation to pay $4.4 million to 3M Diagnostic Systems, Inc. as part of the purchase price for the September 1991 acquisition of the business and assets of that company. BioWhittaker, which had the option of making the payment in cash or common stock, secured a $4.5 million loan from NationsBank to fund the cash payment.
 BioWhittaker, Inc. develops and produces clinical diagnostic testing systems, cell culture products, and endotoxin detection assays for the international healthcare and biotechnology markets.
 -0- 2/5/93
 /CONTACT: James D. Werner Jr. of BioWhittaker, 301-898-7025, ext. 2330/
 (BWI)


CO: BioWhittaker, Inc.; 3M Diagnostic Systems, Inc. ST: Maryland IN: MTC SU:

IH -- DC002 -- 3357 02/05/93 08:04 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Feb 5, 1993
Words:133
Previous Article:HELIONETICS ANNOUNCES COMPLETION OF OFFSHORE FINANCING
Next Article:SMALL BUSINESS GUIDE TO THE FAMILY AND MEDICAL LEAVE ACT
Topics:


Related Articles
BIOWHITTAKER ANNOUNCES RESULTS
BIOWHITTAKER ANNOUNCES THAT IT WILL INCUR A $1.1 MILLION NONRECURRING CHARGE IN SECOND QUARTER
BIOWHITTAKER TO PROCEED WITH DEVELOPMENT OF TEST FOR ENDOTOXEMIA
BIOWHITTAKER ANNOUNCES STRONG REBOUND IN EARNINGS FOR FYE 10/31/94
BIOWHITTAKER RENEWS STOCKHOLDER RIGHTS PLAN
BIOWHITTAKER ANNOUNCES SECOND QUARTER EARNINGS
BIOWHITTAKER EARNINGS AFFECTED BY ACQUISITION AND DIVESTITURE
BioWhittaker Announces Record Quarterly Sales and Earnings
Cambrex and BioWhittaker Agree to Cambrex Acquisition of BioWhittaker
Cambrex Cash Tender Offer for BioWhittaker Succeeds; 93% Of Shares Support Cambrex Offer

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters